Abstract:Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has long been thought to exert its benefits by reducing cholesterol synthesis, and has been shown to significantly reduce cardiovascular events and mortality in patients with or without coronary artery disease. However, it is still unknown whether acute administration of simvastatin beneficially affects the cardiac function prior or during ischemia–reperfusion. The aim of this study is to evaluate the cardioprotective effect of acute simvastatin treatment on isolated rat hearts or isolated ischemia–reperfusion hearts. Hearts were isolated from male Sprague–Dawley rats and attached to a Langendorff apparatus. The isolated hearts with or without ischemia (15 min) and reperfusion (60 min) were perfused with different concentrations of simvastatin. The parameters of cardiac function (such as left ventricular developed pressure [LVDP], +d p /d t max, and −d p /d t max), heart rate, and coronary flow were recorded. Simvastatin (3–30 µmol/l) significantly increased LVDP, +d p /d t max, and −d p /d t max in isolated rat hearts perfused for 60 min. Heart rate was depressed by 30 µmol/l simvastatin and the coronary flow was increased by 10 and 30 µmol/l simvastatin. At a concentration of 100 µmol/l simvastatin, worsening of heart function and subsequent cardiac arrest occurred. Administration of simvastatin (3–30 µmol/l) significantly preserved cardiac function detected by LVDP, +d p /d t max, and −d p /d t max in the isolated ischemia/reperfused (15/60 min) rat hearts. Simvastatin also significantly decreased heart rate at 30 µmol/l, and increased coronary flow at 10 and 30 µmol/l in these rat hearts. However, the protective effect of simvastatin reverted to increased damage at 100 µmol/l. Only 3 µmol/l simvastatin pretreatment before 15/60 min ischemia–reperfusion altered LVDP, +d p /d t max, and −d p /d t max. Both heart rate and coronary flow were unaltered after simvastatin pretreatment. Since simvastatin at a concentration lower than 100 µmol/l exerted beneficial effects on cardiac function in isolated perfused rat hearts, it could be applied just after myocardial ischemia and reperfusion.

Apoptosis Induced by Simvastatin in Rat Vascular Smooth Muscle Cells Through Calpain and Caspase-3-dependent Pathways

Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway.

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Effects of Simvastatin on Cardiac Performance and Expression of Sarco-Plasmic Reticular Calcium Regulatory Proteins in Rat Heart

Effects of simvastatin on cardiohemodynamic responses to ischemia–reperfusion in isolated rat hearts

Atorvastatin inhibits the H2O2-induced apoptosis of human vascular endothelial cells through a down-regulation of cleaved caspase-9/caspase-3

Tissue-specific Effects of Atorvastatin on 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expression and Activity in Spontaneously Hypertensive Rats

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

Simvastatin inhibit proliferation in vascular smooth muscle cells in association with induction of PTEN and p27

Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice

Short-Term Pretreatment with Atorvastatin Attenuates Left Ventricular Dysfunction, Reduces Infarct Size and Apoptosis in Acute Myocardial Infarction Rats

Simvastatin Suppresses Apoptosis in Vulnerable Atherosclerotic Plaques Through Regulating the Expression of P(53), Bcl-2 and Bcl-Xl

Enhancement of Autophagy by Simvastatin through Inhibition of Rac1‐mTOR Signaling Pathway

The Effects of Atorvastatin on Left Ventricular Remodeling in Spontaneously Hypertensive Rats

[Simvastatin Inhibits Hypertension-Induced Cardiac Hypertrophy in Rats Through Activation of Heme Oxygenase-1/Carbon Monoxide Pathway].

Simvastatin Protects Cardiomyocytes Against Endotoxin-induced Apoptosis and Up-regulates Survivin/NF-κB/p65 Expression

[Effect of simvastatin on the proliferation of human omental preadipocytes and caspase-3 expression]

Simvastatin Induces Apoptosis but Attenuates Migration in SCAPs

Effect of Oxidated Low-Density Lipoprotein on Early Apoptosis of Vascular Smooth Muscle Cell

Effect of Simvastatin on the Proliferation and Migration of Vascular Smooth Muscle Cells

Simvastatin Induces Heme Oxygenase-1